» Articles » PMID: 31467567

Surfactant Protein D Is Altered in Experimental Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome

Overview
Journal J Trop Med
Publisher Wiley
Specialty Tropical Medicine
Date 2019 Aug 31
PMID 31467567
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Surfactant protein D (SP-D) is in the collectin family of C-type lectins and plays an important role in the regulation of inflammation and the innate immune defense against pathogens. This protein has been proposed as a biomarker for acute lung injury. However, the expression of SP-D in the lung and the circulating levels of SP-D during malaria infection have received limited attention. Therefore, the aim of this study was to determine the location and expression of the SP-D protein in lung tissue and to measure the plasma level of SP-D in experimental malaria-associated acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Malaria-infected mice induced by ANKA were classified into two groups, namely, the ALI/ARDS and non-ALI/ARDS groups, according to lung histopathology. The lungs of uninfected mice were used as a control group. The location and expression of SP-D in the lung tissues were investigated by immunohistochemical staining and Western blot analysis. In addition, the level of SP-D in plasma and lung homogenate was measured by an enzyme-linked immunosorbent assay. Immunohistochemical staining of SP-D was significantly increased in the lung tissues of the malaria-infected mice in the ALI/ARDS group compared with that in the malaria-infected mice in the non-ALI/ARDS group and the mice in the control group ( < 0.05). The levels of SP-D in the plasma and lung homogenate were significantly increased in the malaria-infected mice in the ALI/ARDS group compared with those in the malaria-infected mice in the non-ALI/ARDS group and the mice in the control group ( < 0.05). There was a significant positive correlation between SP-D in the plasma and SP-D in the lung homogenate ( = 0.900, = 0.037). In conclusion, this study demonstrated increased expression levels of SP-D in the lung tissue and high levels of plasma SP-D in the malaria-infected mice with ALI/ARDS compared with those in the mice in the other groups. The current study supports that the elevation of the plasma SP-D level may provide useful biological confirmation of the diagnosis of ALI/ARDS during malaria infection.

Citing Articles

Circulating Surfactant Protein D: A Biomarker for Acute Lung Injury?.

Elmore A, Almuntashiri A, Wang X, Almuntashiri S, Zhang D Biomedicines. 2023; 11(9.

PMID: 37760958 PMC: 10525947. DOI: 10.3390/biomedicines11092517.


The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model.

Fei L, Sun G, Sun J, Wu D Bioengineered. 2022; 13(3):7622-7634.

PMID: 35263199 PMC: 8973778. DOI: 10.1080/21655979.2022.2049473.

References
1.
Greene K, Wright J, Steinberg K, Ruzinski J, Caldwell E, Wong W . Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999; 160(6):1843-50. DOI: 10.1164/ajrccm.160.6.9901117. View

2.
Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U . Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol. 2000; 164(11):5866-70. DOI: 10.4049/jimmunol.164.11.5866. View

3.
Crouch E . Surfactant protein-D and pulmonary host defense. Respir Res. 2001; 1(2):93-108. PMC: 59549. DOI: 10.1186/rr19. View

4.
Pan T, Nielsen L, Allen M, Shannon K, Shannon J, Selman M . Serum SP-D is a marker of lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2002; 282(4):L824-32. DOI: 10.1152/ajplung.00421.2000. View

5.
Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N . Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. Rheumatology (Oxford). 2002; 41(11):1268-72. DOI: 10.1093/rheumatology/41.11.1268. View